ID   INT-MEL-58
AC   CVCL_F249
SY   Me9229; Me 9229; 9229; Melanoma 9229
DR   CLO; CLO_0001014
DR   CLDB; cl139
DR   Wikidata; Q54897808
RX   DOI=10.1007/0-306-46872-7_16;
RX   PubMed=2469723;
RX   PubMed=3121738;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
RX   DOI=10.1007/0-306-46872-7_16;
RA   Anichini A., Mortarini R., Vegetti C., Molla A., Borri A., Parmiani G.;
RT   "Melanoma: the Milan melanoma cell lines.";
RL   (In book chapter) Human cell culture. Vol. 1. Cancer cell lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.283-292; Kluwer Academic Publishers; New York; USA (1999).
//
RX   PubMed=2469723; DOI=10.4049/jimmunol.142.10.3692;
RA   Anichini A., Mazzocchi A., Fossati G., Parmiani G.;
RT   "Cytotoxic T lymphocyte clones from peripheral blood and from tumor
RT   site detect intratumor heterogeneity of melanoma cells. Analysis of
RT   specificity and mechanisms of interaction.";
RL   J. Immunol. 142:3692-3701(1989).
//
RX   PubMed=3121738; DOI=10.4049/jimmunol.140.1.183;
RA   Anichini A., Castelli C., Sozzi G., Fossati G., Parmiani G.;
RT   "Differential susceptibility to recombinant interferon-gamma-induced
RT   HLA-DQ antigen modulation among clones from a human metastatic
RT   melanoma.";
RL   J. Immunol. 140:183-191(1988).
//